How to use the speech recognition tool?
An Open-Label Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B
An Open-Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B.
Status of the trial: Completed
Orphan Drug Recognition: NA
- Opening Date: 2015-11-27
- Closing Date: 2035-03-20
Inclusion: Provide signed and dated written informed consent (and if appropriate assent) and any locally required authorization eg, Health Insurance Portability and Accountability Act (HIPAA). Must have been enrolled in Protocol TDU13600 Must have received a subreti
Exclusion: Did not receive UshStat® as part of the TDU13600 protocol.
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
- Retinal Rare Eye Diseases (WG1)
This ERN is supported by: